NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,075,025 | +348.5% | 66,565 | +1570.0% | 0.03% | +285.7% |
| Q1 2023 | $239,718 | -23.2% | 3,986 | -6.4% | 0.01% | -22.2% |
| Q4 2022 | $312,324 | -44.9% | 4,258 | -37.7% | 0.01% | -66.7% |
| Q1 2022 | $567,000 | -74.7% | 6,840 | -77.1% | 0.03% | -80.4% |
| Q4 2021 | $2,241,000 | +47.4% | 29,851 | +128.1% | 0.14% | +14.0% |
| Q3 2021 | $1,520,000 | -16.0% | 13,088 | -4.3% | 0.12% | -27.1% |
| Q1 2021 | $1,809,000 | +7.3% | 13,683 | -9.7% | 0.17% | +53.7% |
| Q3 2020 | $1,686,000 | +35.1% | 15,147 | -28.0% | 0.11% | +24.1% |
| Q2 2020 | $1,248,000 | +61.2% | 21,052 | +83.1% | 0.09% | +55.4% |
| Q1 2020 | $774,000 | -57.0% | 11,498 | -52.2% | 0.06% | -63.9% |
| Q3 2019 | $1,800,000 | +15.2% | 24,067 | -25.8% | 0.16% | +39.6% |
| Q1 2019 | $1,563,000 | +554.0% | 32,438 | +355.1% | 0.11% | +640.0% |
| Q4 2018 | $239,000 | -53.9% | 7,128 | -72.2% | 0.02% | -73.7% |
| Q4 2017 | $518,000 | +144.3% | 25,648 | +139.9% | 0.06% | +7.5% |
| Q3 2017 | $212,000 | – | 10,690 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
| MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
| Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
| Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
| HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
| Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |